中國重汽(03808.HK):濟南卡車配售的所有先決條件已達成
格隆匯3月11日丨中國重汽(03808.HK)公佈,董事會已接獲濟南卡車通知,建議配售的所有先決條件已達成,根據建議配售發行的濟南卡車股份已於2021年3月9日在中國證券登記結算有限責任公司深圳分公司登記,並將於2021年3月15日在深圳證券交易所上市。
合共168,111,600股濟南卡車股份已按認購價每股濟南卡車股份人民幣29.82元向23名目標認購人發行及配售。建議配售所得款項總額為人民幣5,013,087,912.00元,而所得款項淨額為人民幣5,001,383,278.41元。
根據建議配售結果,公司於濟南卡車的股權由約63.78%減少約12.78%至51%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.